27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
On CNBC’s "Mad Money Lightning Round," Jim Cramer said ADMA Biologics, Inc. (NASDAQ:ADMA) is a "great spec, but it is losing money hand over fist. I think it’s very binary. I can not like binary situations."
Analysts disagree, according to Benzinga data, ADMA has a consensus Buy rating.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
When asked about Rite Aid Corporation (NYSE:RAD), he said, "We don’t want Rite Aid. Why don’t we buy CVS Health Corporation (NYSE:CVS)?"
Cramer said he likes WESCO International (NYSE:WCC) very much. "I think you have a winner," he added.
When asked about AT&T Inc. (NYSE:T), Cramer said, "T-Mobile US, Inc. (NASDAQ:TMUS) is the class of the field." AT&T is not as bad as it used to be, he added.
Don’t forget to check out our premarket coverage here .
The "Mad Money" host said he prefers Sempra (NYSE:SRE) over NextDecade Corporation (NASDAQ:NEXT).
When asked about Array Technologies, Inc. (NASDAQ:ARRY), he said, "If they make the money that they’re supposed to make this year, then I think you’ll be in very good shape."
Cramer said FREYR Battery (NYSE:FREY) is losing too much money. "That’s too tough," he added.
Now Read This: $3.4 Million Bet On CrowdStrike Holdings? Check Out These 3 Stocks Insiders Are Buying
Photo: Courtesy of Scott Beale on flickr
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.